GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Essilorluxottica (OTCPK:ESLOF) » Definitions » Debt-to-EBITDA
中文

Essilorluxottica (Essilorluxottica) Debt-to-EBITDA

: 2.01 (As of Dec. 2023)
View and export this data going back to 2009. Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

Essilorluxottica's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2,943 Mil. Essilorluxottica's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $9,769 Mil. Essilorluxottica's annualized EBITDA for the quarter that ended in Dec. 2023 was $6,321 Mil. Essilorluxottica's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 2.01.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Essilorluxottica's Debt-to-EBITDA or its related term are showing as below:

ESLOF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.01   Med: 1.94   Max: 4.56
Current: 1.89

During the past 13 years, the highest Debt-to-EBITDA Ratio of Essilorluxottica was 4.56. The lowest was 1.01. And the median was 1.94.

ESLOF's Debt-to-EBITDA is ranked worse than
60.51% of 428 companies
in the Medical Devices & Instruments industry
Industry Median: 1.225 vs ESLOF: 1.89

Essilorluxottica Debt-to-EBITDA Historical Data

The historical data trend for Essilorluxottica's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essilorluxottica Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.46 4.56 2.76 2.00 1.89

Essilorluxottica Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.68 2.25 2.07 1.79 2.01

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Essilorluxottica's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Essilorluxottica Debt-to-EBITDA Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Essilorluxottica's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Essilorluxottica's Debt-to-EBITDA falls into.



Essilorluxottica Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Essilorluxottica's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2943.293 + 9768.811) / 6739.368
=1.89

Essilorluxottica's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2943.293 + 9768.811) / 6320.61
=2.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Essilorluxottica  (OTCPK:ESLOF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Essilorluxottica Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Essilorluxottica's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Essilorluxottica (Essilorluxottica) Business Description

Address
147, Rue de Paris, Charenton-Le-Pont, Paris, FRA, 94220
EssilorLuxottica is a combination of the leading manufacturer of premium frames and sunglasses and the leading manufacturer of optical lenses. Both companies are significantly larger than the next biggest player in their respective fields and command over 15% of the fragmented global eyewear market. The company has a broad geographical presence, with around 36% of sales in Europe, 47% in North America, and the rest in Asia and Latin America.

Essilorluxottica (Essilorluxottica) Headlines

From GuruFocus

Daniel Loeb Comments on EssilorLuxottica

By Sydnee Gatewood Sydnee Gatewood 04-22-2020

Daniel Loeb Comments on EssilorLuxottica

By Sydnee Gatewood Sydnee Gatewood 10-24-2019

Dan Loeb Buys David Herro Stock EssilorLuxottica

By Holly LaFon Holly LaFon 08-26-2019

Chris Davis Comments on Essilor International SA

By Vera Yuan Vera Yuan 09-09-2014

TOCQUEVILLE ASSET MANAGEMENT L.P. Cuts Portfolio Down to Size in 1st Quarter

By GuruFocus Research GuruFocus Editor 05-19-2022